JHEP Reports
@JHEP_Reports
Followers
5K
Following
187
Media
1K
Statuses
2K
JHEP Reports publishes manuscripts concerned with basic, translational and clinical research in the field of hepatology - IF: 7.5
Genève, Suisse
Joined October 2018
📢Our September issue is out❗️ Featured article: 🟣Navigating liver toxicity in the age of novel oncological agents: https://t.co/wmUU0qa9b6 Check out the full issue now👇 https://t.co/uwGNHfFY63
#LiverTwitter
@EASLedu
@EASLnews
0
4
10
🟣Profiles of HBV DNA integration in humans with hepatitis B virus infection: Insights for antiviral treatment 🔓#OpenAccess at👉 https://t.co/7EsfwrCEVU
#HBV
#LiverX
#LiverTwitter
0
0
6
🟣All-cause and disease-specific mortality in young adults with #MASLD: A nationwide cohort study 🔓#OpenAccess at 👉 https://t.co/eySDX134tM
#LiverTwitter
#LiverX
0
2
6
🟣GDF15 is associated with hepatocellular senescence and correlates with mortality in patients with alcohol-associated hepatitis 🔓#OpenAccess at👉 https://t.co/vKvh4fTcUz
#LiverTwitter
#LiverDisease
@rabataller
@RautouE
1
8
18
🚨Novel cancer TXs have revolutionized outcomes, but DILI is an emerging challenge. ✅ DILI is a diagnosis of exclusion ✅ Corticosteroids remain cornerstone for severe cases ✅ Rechallenge must be individualised ✅ Multidisciplinary management is 🔑 👉 https://t.co/PrwlKzfzxS
0
2
5
🟣Attributable burden of steatotic liver disease on cardiovascular outcomes in Asia 🔓#OpenAccess at 👉 https://t.co/AvDfLRm7Sf
#LiverTwitter
#LiverDisease
#SteatoticLiverDisease
0
4
14
🟣Impact of genetic variants linked to liver fat and liver volume on MRI-mapped body composition 🔓#OpenAccess at 👉 https://t.co/TxHiwbaUDB
#LiverTwitter
#LiverX
#LiverDisease
1
0
8
In today’s #readoftheweek📚, we spotlight a study on stereotactic body radiotherapy. The authors examined its safety and outcomes in patients with hepatocellular carcinoma awaiting liver transplantation. Read here this @JHEP_Reports article: https://t.co/Q6kvssawOu 🙏
0
5
7
In today’s #readoftheweek📚, learn how transformer neural networks on liver MRI data can be used to enhance cardiovascular risk prediction. Read here this @JHEP_Reports article: https://t.co/qT2lc50ia3 🙏@JClusmann, @tom_luedde, @DanielTruhn, @jnkath et al. #LiverX
1
3
3
In today’s #readoftheweek📚, the authors explore how TIPS could limit the risk of portal hypertensive complications in patients with ascites. Read here this @JHEP_Reports article: https://t.co/Img7vfGIIt 🙏@balcar_lorenz, @hartl_md, @MattiasMandorf1, @ProfPaoloAngeli,
0
8
20
Our tribute to a giant of hepatology, Prof. Michael Manns. His legacy will endure, rest in peace.
EASL is deeply saddened to share the news of the passing of Professor Michael P. Manns (1951–2025). A visionary leader in hepatology, Professor Manns shaped the field through his pioneering research in viral hepatitis, autoimmune liver diseases, transplantation and regenerative
0
3
6
📢Our August issue is out❗️ Featured article: 🟣Risk of portal hypertensive complications preventable by TIPS in patients with ascites: https://t.co/KcUxom8GEV 📖 Dive into the full issue now 👉 https://t.co/6Hyce6IQfP
#LiverTwitter
@EASLedu
@EASLnews
0
14
27
Today’s #readoftheweek📚highlights the importance of the biomarkers phosphatidylethanol and ethyl glucuronide, and their ability in detecting any alcohol use and rule out increased alcohol use in patients with alcohol-related #cirrhosis. Read here this @JHEP_Reports article:
0
7
21
🟣Temporal dichotomy of neutrophil function in acute liver injury and repair 🔓#OpenAccess at 👉 https://t.co/qJxGY5diPY
#LiverTwitter
#LiverDisease
0
2
15
🧬 New in August: https://t.co/3luNF0Jt9P 📅 Detection windows: uEtG → 3d - PEth → 3w - hEtG/nEtG → 3m 📊 Useful for MASLD/MetALD classification & trials. ✅ Biomarkers support objective classification of alcohol exposure. 🔁 Serial measurements may improve interpretation.
1
8
24
🟪NEW Article in press❕ NTCP ubiquitination enables Hepatitis B Virus (HBV) infection 🔓#OpenAccess at 👉 https://t.co/jDDWAt7Zom
#LiverTwitter
#HBV
0
2
4
🟣Prediction of long-term HBsAg seroclearance in patients with HBeAg-negative chronic hepatitis B 🔓#OpenAccess at 👉 https://t.co/7lJjXtRmP5
#HBV
#LiverTwitter
0
4
13
🟪NEW Article in press❕ Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis in Asia 🔓#OpenAccess at 👉 https://t.co/pJIestqfU1
#HCC
#Hepatitis
#LiverTwitter
0
4
9
The authors of today’s #readoftheweek📚 discuss the use of invasive coronary angiography in #livertransplant candidates. Read here this @JHEP_Reports article: https://t.co/E08LWjl5Nk 🙏@Giulia76907046, @sbrugaletta, @AnderRegueiro, @ColmeneroJordi, @goncrespo1 et al. #LiverX
0
10
13
🟪NEW Article in press❕ Randomized phase II study comparing two doses of regorafenib in second-line treatment for advanced hepatocellular carcinoma 🔓#OpenAccess at 👉 https://t.co/a6OdbPDomE
#LiverTwitter
#LiverX
#HCC
0
2
4